Results 71 to 80 of about 22,551 (179)
Epidermolysis bullosa acquisita localized to the face
, 1998 A 39-year-old woman had a three-year history of recurrent bullous eruption localized to her left cheek. The diagnosis of epidermolysis bullosa acquisita was confirmed by means of direct immunofluorescence and direct immunoelectron microscopic studies ...
김수찬
core +1 more source
Epidermolysis bullosa acquisita associated with epidermal-binding circulating antibodies
Epidermolysis bullosa acquisita (EBA) is a rare, immunobullous disease, characterized by circulating and tissue-bound antibodies against type VII collagen (C7) of anchoring fibrils in the cutaneous basement membrane zone, These antibodies localize to the
Bhogal B +7 more
core +4 more sources
A Case of Palmoplantar Vesiculobullous Lesions
JEADV Clinical Practice, Volume 5, Issue 1, Page 315-318, March 2026.
Ali Abid +3 more
wiley +1 more source
The Journal of Dermatology, Volume 52, Issue 5, Page 812-830, May 2025.Abstract Patients with autoimmune bullous disease have their quality of life (QOL) affected by both the disease and its treatment burden. While QOL assessment is clinically important, it is often hindered by limited time in clinical practice, highlighting the need for accurate and efficient QOL evaluation tools. However, no validated QOL questionnaires
Chika Tanemura +17 more
wiley +1 more source
Heavy and Light Chain Isotypes of Immunoglobulin in Epidermolysis Bullosa Acquisita [PDF]
, 1990 Epidermolysis bullosa acquisita (EBA) is a chronic acquired blistering disease with characteristic clinical, pathologic, and immunopathologic features.
Gammon, W Ray, Mooney, Ellen
core +1 more source
Epidermolysis bullosa acquisita (EBA) and acquired hemophilia A (AHA) are two rare autoimmune disorders. Respectively, EBA is an autoimmune blistering disease (AIBD) of the skin and mucous membranes, elicited by IgG autoantibodies against the collagen ...
Hertl, Michael +4 more
core +1 more source
Orphanet Journal of Rare Diseases, 2018 Background Epidermolysis bullosa acquisita (EBA) is an orphan autoimmune disease. Several clinical phenotypes have been described, but subepidermal blistering is characteristic of all variants.
Hiroaki Iwata +8 more
doaj +1 more source
Bullous Type 2 Lepra Reaction: A Rare and Significant Case Report
Clinical Case Reports, Volume 13, Issue 1, January 2025.ABSTRACT Bullous type 2 lepra reactions are a rare initial presentation in leprosy that can complicate the disease with vesiculo‐bullous lesions. Early recognition and differentiation from other bullous disorders are critical for timely corticosteroid and multidrug therapy initiation to improve patient outcomes.
Hrithik Dakssesh Putta Nagarajan +6 more
wiley +1 more source
Fcγ Receptor IIB Controls Skin Inflammation in an Active Model of Epidermolysis Bullosa Acquisita
Frontiers in Immunology, 2020 Epidermolysis bullosa acquisita (EBA) is an autoimmune skin blistering disease characterized by IgG autoantibodies (aAb) against type VII collagen (COL7).
Balint Kovacs +10 more
doaj +1 more source
JAK Inhibitors for Pemphigoid Diseases
Dermatologic Therapy, Volume 2025, Issue 1, 2025.Pemphigoid diseases are a group of chronic autoimmune blistering skin disorders, with bullous pemphigoid representing the most prevalent subtype. Bullous pemphigoid (BP) primarily affects individuals aged 60–80 years, and its incidence has been steadily rising in correlation with increasing life expectancy and population aging in Western countries ...
Enkhbilguun Sodbuyan +3 more
wiley +1 more source